Clinical Trials Browser

Phase 1/2 × INDUSTRY × icotinib × Clear all

NCT01516983 2014-02-17

Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation

Phase 1/2 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung